Indegene (BSE:544172) - Stock Price, News & Analysis

544172 Stock Overview

Operates as a life sciences commercialization company in India and internationally.

544172 fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	5/6
Financial Health	5/6
Dividends	0/6

Rewards

Earnings grew by 26.5% over the past year

Risk Analysis

No risks detected for 544172 from our risk checks.

Indegene Limited Competitors

Syngene International

NSEI:SYNGENE

₹284.7b

Innova Captab

NSEI:INNOVACAP

₹28.9b

Tarsons Products

NSEI:TARSONS

₹27.3b

Windlas Biotech

NSEI:WINDLAS

₹15.4b

Price History & Performance

Summary of all time highs, changes and price drops for Indegene
Historical stock prices
Current Share Price	₹552.30
52 Week High	₹659.70
52 Week Low	₹468.90
Beta	0
11 Month Change	5.82%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-3.22%

Recent updates

Shareholder Returns

	544172	IN Life Sciences	IN Market
7D	-3.9%	0.7%	1.4%
1Y	n/a	21.3%	44.3%

Return vs Industry: Insufficient data to determine how 544172 performed against the Indian Life Sciences industry.

Return vs Market: Insufficient data to determine how 544172 performed against the Indian Market.

Price Volatility

Is 544172's price volatile compared to industry and market?
544172 volatility
544172 Average Weekly Movement	5.8%
Life Sciences Industry Average Movement	5.7%
Market Average Movement	6.4%
10% most volatile stocks in IN Market	9.6%
10% least volatile stocks in IN Market	4.2%

Stable Share Price: 544172 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 544172's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1998	5,181	Manish Gupta	www.indegene.com

Indegene Limited operates as a life sciences commercialization company in India and internationally. The company develops biotech and medical device through biopharmaceutical life cycle. It also offers enterprise commercial, medical, and clinical solutions.

Indegene Limited Fundamentals Summary

How do Indegene's earnings and revenue compare to its market cap?
544172 fundamental statistics
Market cap	₹122.90b
Earnings (TTM)	₹3.37b
Revenue (TTM)	₹25.90b

36.5x

P/E Ratio

4.7x

P/S Ratio

Is 544172 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
544172 income statement (TTM)
Revenue	₹25.90b
Cost of Revenue	₹0
Gross Profit	₹25.90b
Other Expenses	₹22.53b
Earnings	₹3.37b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	15.14
Gross Margin	100.00%
Net Profit Margin	13.00%
Debt/Equity Ratio	28.2%

How did 544172 perform over the long term?

See historical performance and comparison

Indegene BSE:544172 Stock Report